Transgene Biotek Cash Flow Annual

Trade
BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs
6.52 +0.03 (0.46%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line -0.66-6.01-10.40-10.43
Depreciation/ Depletion 0.094.959.929.91
Non- Cash Items -0.050.010.050.09
Changesin Working Capital 0.611.050.520.45
Cashfrom Operating Activities 0.000.000.100.01
Other Investing Cash Flow Items Total 0.000.00-0.10-
Cashfrom Investing Activities 0.00-0.01-0.10-0.03
Financing Cash Flow Items 0.00---
Cashfrom Financing Activities 0.000.000.000.00
Net Changein Cash 0.00-0.010.00-0.01
Capital Expenditures --0.010.00-0.03
Issuance( Retirement)of Debt Net -0.000.00-
Issuance( Retirement)of Stock Net ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,504.70+44.10(1.79%)
1,921.85+32.70(1.73%)
589.05+6.30(1.08%)
11,105.00-351.85 (-3.07%)
HomeMarketsPremiumInstant LoanMint Shorts